Product Introduction:
Telmed Beta 40/50 ER Tablet is a fixed-dose combination medication containing Telmisartan (40 mg) and Metoprolol Succinate (50 mg Extended Release). Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels, while Metoprolol is a beta-blocker that lowers heart rate and cardiac output. Together, they provide effective control of blood pressure and reduce the risk of cardiovascular events.
Uses:
-
Management of hypertension (high blood pressure)
-
Prevention of heart attack and stroke
-
Supportive therapy in heart failure and coronary artery disease
-
Kidney protection in hypertensive diabetic patients
Benefit:
-
Effectively reduces and maintains healthy blood pressure levels
-
Protects heart and kidneys from damage
-
Helps in long-term cardiovascular risk reduction
-
Extended-release formula provides steady control over 24 hours
Composition:
-
Telmisartan 40 mg
-
Metoprolol Succinate 50 mg (Extended Release)
Side Effects:
-
Dizziness or fatigue
-
Slow heartbeat
-
Cold hands and feet
-
Nausea or upset stomach
-
Increased potassium levels (rare)
-
Bradycardia or low blood pressure (in sensitive individuals)
Safety Advice:
-
Take once daily with food, preferably at the same time each day
-
Do not stop the medicine abruptly without medical advice
-
Monitor blood pressure, heart rate, and electrolytes regularly
-
Inform your doctor if pregnant, breastfeeding, or having liver/kidney/heart conditions
-
Avoid alcohol and sudden position changes to prevent dizziness
